nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—CYP2D6—Hydroxyurea—head and neck cancer	0.163	0.31	CbGbCtD
Dronedarone—ALB—Fluorouracil—head and neck cancer	0.127	0.24	CbGbCtD
Dronedarone—ABCB1—Vinblastine—head and neck cancer	0.0614	0.117	CbGbCtD
Dronedarone—CYP2D6—Vinblastine—head and neck cancer	0.0579	0.11	CbGbCtD
Dronedarone—ABCB1—Docetaxel—head and neck cancer	0.0506	0.096	CbGbCtD
Dronedarone—CYP3A4—Vinblastine—head and neck cancer	0.0368	0.0698	CbGbCtD
Dronedarone—CYP3A4—Docetaxel—head and neck cancer	0.0303	0.0575	CbGbCtD
Dronedarone—CACNA1D—cochlea—head and neck cancer	0.0215	0.108	CbGeAlD
Dronedarone—CACNA1D—internal ear—head and neck cancer	0.0204	0.102	CbGeAlD
Dronedarone—CACNA1D—ear—head and neck cancer	0.0138	0.0687	CbGeAlD
Dronedarone—Pulmonary fibrosis—Hydroxyurea—head and neck cancer	0.0133	0.0907	CcSEcCtD
Dronedarone—HCN1—head—head and neck cancer	0.0121	0.0604	CbGeAlD
Dronedarone—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.00921	0.0628	CcSEcCtD
Dronedarone—HCN4—head—head and neck cancer	0.00917	0.0458	CbGeAlD
Dronedarone—Atrial flutter—Docetaxel—head and neck cancer	0.008	0.0545	CcSEcCtD
Dronedarone—HCN3—head—head and neck cancer	0.00741	0.037	CbGeAlD
Dronedarone—CACNA1F—head—head and neck cancer	0.00695	0.0347	CbGeAlD
Dronedarone—HCN2—head—head and neck cancer	0.00695	0.0347	CbGeAlD
Dronedarone—Pulmonary fibrosis—Docetaxel—head and neck cancer	0.00691	0.0471	CcSEcCtD
Dronedarone—CACNB4—thyroid gland—head and neck cancer	0.00515	0.0257	CbGeAlD
Dronedarone—Amiodarone—CYP1A1—head and neck cancer	0.00509	1	CrCbGaD
Dronedarone—CACNB3—trachea—head and neck cancer	0.00499	0.0249	CbGeAlD
Dronedarone—CACNB4—head—head and neck cancer	0.00457	0.0228	CbGeAlD
Dronedarone—KCNK2—thyroid gland—head and neck cancer	0.00457	0.0228	CbGeAlD
Dronedarone—CACNA1S—thyroid gland—head and neck cancer	0.00441	0.022	CbGeAlD
Dronedarone—Interstitial lung disease—Docetaxel—head and neck cancer	0.0043	0.0293	CcSEcCtD
Dronedarone—CACNB1—thyroid gland—head and neck cancer	0.00411	0.0205	CbGeAlD
Dronedarone—Dermatitis atopic—Docetaxel—head and neck cancer	0.00411	0.028	CcSEcCtD
Dronedarone—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00398	0.0271	CcSEcCtD
Dronedarone—Rash erythematous—Docetaxel—head and neck cancer	0.00397	0.0271	CcSEcCtD
Dronedarone—CACNB3—thyroid gland—head and neck cancer	0.00395	0.0197	CbGeAlD
Dronedarone—Ageusia—Docetaxel—head and neck cancer	0.00375	0.0256	CcSEcCtD
Dronedarone—CACNB1—head—head and neck cancer	0.00365	0.0182	CbGeAlD
Dronedarone—CACNB3—head—head and neck cancer	0.0035	0.0175	CbGeAlD
Dronedarone—ADRA1D—epithelium—head and neck cancer	0.00328	0.0164	CbGeAlD
Dronedarone—CACNA1C—connective tissue—head and neck cancer	0.00322	0.0161	CbGeAlD
Dronedarone—Cardiac failure—Fluorouracil—head and neck cancer	0.00313	0.0214	CcSEcCtD
Dronedarone—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.0031	0.0211	CcSEcCtD
Dronedarone—KCNK2—lymph node—head and neck cancer	0.00284	0.0142	CbGeAlD
Dronedarone—Angiopathy—Hydroxyurea—head and neck cancer	0.00267	0.0182	CcSEcCtD
Dronedarone—CACNB2—thyroid gland—head and neck cancer	0.00265	0.0132	CbGeAlD
Dronedarone—Erythema—Hydroxyurea—head and neck cancer	0.00256	0.0174	CcSEcCtD
Dronedarone—CACNB1—lymph node—head and neck cancer	0.00256	0.0128	CbGeAlD
Dronedarone—ADRB1—connective tissue—head and neck cancer	0.00251	0.0126	CbGeAlD
Dronedarone—CACNB3—lymph node—head and neck cancer	0.00245	0.0122	CbGeAlD
Dronedarone—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00243	0.0166	CcSEcCtD
Dronedarone—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00241	0.0164	CcSEcCtD
Dronedarone—Pneumonia—Fluorouracil—head and neck cancer	0.00237	0.0162	CcSEcCtD
Dronedarone—CACNB2—head—head and neck cancer	0.00235	0.0117	CbGeAlD
Dronedarone—CACNA1D—thyroid gland—head and neck cancer	0.00232	0.0116	CbGeAlD
Dronedarone—SCN1A—head—head and neck cancer	0.00229	0.0114	CbGeAlD
Dronedarone—Cardiac failure—Docetaxel—head and neck cancer	0.00226	0.0154	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00216	0.0147	CcSEcCtD
Dronedarone—ADRA2C—parotid gland—head and neck cancer	0.00215	0.0107	CbGeAlD
Dronedarone—ADRA1B—head—head and neck cancer	0.00208	0.0104	CbGeAlD
Dronedarone—CACNA1D—head—head and neck cancer	0.00206	0.0103	CbGeAlD
Dronedarone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00205	0.014	CcSEcCtD
Dronedarone—ADRA1D—head—head and neck cancer	0.00204	0.0102	CbGeAlD
Dronedarone—Skin disorder—Hydroxyurea—head and neck cancer	0.00203	0.0138	CcSEcCtD
Dronedarone—CACNA1C—head—head and neck cancer	0.0019	0.00948	CbGeAlD
Dronedarone—ADRA1A—epithelium—head and neck cancer	0.00189	0.00942	CbGeAlD
Dronedarone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00187	0.0128	CcSEcCtD
Dronedarone—Erythema—Fluorouracil—head and neck cancer	0.00184	0.0126	CcSEcCtD
Dronedarone—Dyspepsia—Hydroxyurea—head and neck cancer	0.00184	0.0125	CcSEcCtD
Dronedarone—Abdominal pain—Vinblastine—head and neck cancer	0.00181	0.0123	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.0018	0.0123	CcSEcCtD
Dronedarone—Fatigue—Hydroxyurea—head and neck cancer	0.0018	0.0123	CcSEcCtD
Dronedarone—Pneumonia—Docetaxel—head and neck cancer	0.00171	0.0117	CcSEcCtD
Dronedarone—CACNB2—lymph node—head and neck cancer	0.00165	0.00822	CbGeAlD
Dronedarone—Asthenia—Vinblastine—head and neck cancer	0.00164	0.0112	CcSEcCtD
Dronedarone—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00161	0.011	CcSEcCtD
Dronedarone—ADRA2C—trachea—head and neck cancer	0.00159	0.00794	CbGeAlD
Dronedarone—Diarrhoea—Vinblastine—head and neck cancer	0.00157	0.0107	CcSEcCtD
Dronedarone—ADRA2A—connective tissue—head and neck cancer	0.00151	0.00755	CbGeAlD
Dronedarone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0015	0.0102	CcSEcCtD
Dronedarone—Asthenia—Hydroxyurea—head and neck cancer	0.0015	0.0102	CcSEcCtD
Dronedarone—ADRB1—head—head and neck cancer	0.00148	0.00739	CbGeAlD
Dronedarone—Nervous system disorder—Fluorouracil—head and neck cancer	0.00147	0.01	CcSEcCtD
Dronedarone—Vomiting—Vinblastine—head and neck cancer	0.00146	0.00993	CcSEcCtD
Dronedarone—ADRA1A—lymphoid tissue—head and neck cancer	0.00145	0.00726	CbGeAlD
Dronedarone—CACNA1D—lymph node—head and neck cancer	0.00144	0.00719	CbGeAlD
Dronedarone—Diarrhoea—Hydroxyurea—head and neck cancer	0.00143	0.00974	CcSEcCtD
Dronedarone—Cardiac disorder—Docetaxel—head and neck cancer	0.00142	0.00966	CcSEcCtD
Dronedarone—Angiopathy—Docetaxel—head and neck cancer	0.00139	0.00945	CcSEcCtD
Dronedarone—Immune system disorder—Docetaxel—head and neck cancer	0.00138	0.0094	CcSEcCtD
Dronedarone—Mediastinal disorder—Docetaxel—head and neck cancer	0.00138	0.00938	CcSEcCtD
Dronedarone—Nausea—Vinblastine—head and neck cancer	0.00136	0.00927	CcSEcCtD
Dronedarone—Erythema—Docetaxel—head and neck cancer	0.00133	0.00906	CcSEcCtD
Dronedarone—CACNA1C—lymph node—head and neck cancer	0.00133	0.00664	CbGeAlD
Dronedarone—Vomiting—Hydroxyurea—head and neck cancer	0.00133	0.00905	CcSEcCtD
Dronedarone—Dyspepsia—Fluorouracil—head and neck cancer	0.00132	0.00902	CcSEcCtD
Dronedarone—Rash—Hydroxyurea—head and neck cancer	0.00132	0.00898	CcSEcCtD
Dronedarone—Dermatitis—Hydroxyurea—head and neck cancer	0.00132	0.00897	CcSEcCtD
Dronedarone—Dysgeusia—Docetaxel—head and neck cancer	0.0013	0.00887	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.0013	0.00885	CcSEcCtD
Dronedarone—ADRA2A—trachea—head and neck cancer	0.00127	0.00633	CbGeAlD
Dronedarone—Nausea—Hydroxyurea—head and neck cancer	0.00124	0.00846	CcSEcCtD
Dronedarone—ADRA1A—head—head and neck cancer	0.00117	0.00585	CbGeAlD
Dronedarone—KCNH2—head—head and neck cancer	0.00113	0.00565	CbGeAlD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00112	0.00766	CcSEcCtD
Dronedarone—ADRA2C—head—head and neck cancer	0.00112	0.00557	CbGeAlD
Dronedarone—Anaphylactic shock—Docetaxel—head and neck cancer	0.00108	0.0074	CcSEcCtD
Dronedarone—Nervous system disorder—Docetaxel—head and neck cancer	0.00106	0.00725	CcSEcCtD
Dronedarone—Pruritus—Fluorouracil—head and neck cancer	0.00106	0.00725	CcSEcCtD
Dronedarone—Skin disorder—Docetaxel—head and neck cancer	0.00105	0.00718	CcSEcCtD
Dronedarone—ALB—lymph node—head and neck cancer	0.00103	0.00515	CbGeAlD
Dronedarone—Diarrhoea—Fluorouracil—head and neck cancer	0.00103	0.00701	CcSEcCtD
Dronedarone—ADRA2A—thyroid gland—head and neck cancer	0.001	0.00501	CbGeAlD
Dronedarone—Vomiting—Fluorouracil—head and neck cancer	0.000956	0.00652	CcSEcCtD
Dronedarone—Dyspepsia—Docetaxel—head and neck cancer	0.000955	0.00651	CcSEcCtD
Dronedarone—Rash—Fluorouracil—head and neck cancer	0.000948	0.00646	CcSEcCtD
Dronedarone—Dermatitis—Fluorouracil—head and neck cancer	0.000947	0.00646	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000936	0.00639	CcSEcCtD
Dronedarone—Fatigue—Docetaxel—head and neck cancer	0.000935	0.00638	CcSEcCtD
Dronedarone—Nausea—Fluorouracil—head and neck cancer	0.000893	0.00609	CcSEcCtD
Dronedarone—ADRA2A—head—head and neck cancer	0.00089	0.00445	CbGeAlD
Dronedarone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000887	0.00605	CcSEcCtD
Dronedarone—Abdominal pain—Docetaxel—head and neck cancer	0.000857	0.00585	CcSEcCtD
Dronedarone—ABCB1—epithelium—head and neck cancer	0.000799	0.00399	CbGeAlD
Dronedarone—KCNH2—lymph node—head and neck cancer	0.000792	0.00395	CbGeAlD
Dronedarone—ADRA2C—lymph node—head and neck cancer	0.000781	0.0039	CbGeAlD
Dronedarone—Asthenia—Docetaxel—head and neck cancer	0.000778	0.00531	CcSEcCtD
Dronedarone—Pruritus—Docetaxel—head and neck cancer	0.000767	0.00523	CcSEcCtD
Dronedarone—Diarrhoea—Docetaxel—head and neck cancer	0.000742	0.00506	CcSEcCtD
Dronedarone—ABCB1—trachea—head and neck cancer	0.000707	0.00353	CbGeAlD
Dronedarone—Vomiting—Docetaxel—head and neck cancer	0.00069	0.0047	CcSEcCtD
Dronedarone—CYP2D6—head—head and neck cancer	0.000689	0.00344	CbGeAlD
Dronedarone—Rash—Docetaxel—head and neck cancer	0.000684	0.00466	CcSEcCtD
Dronedarone—Dermatitis—Docetaxel—head and neck cancer	0.000683	0.00466	CcSEcCtD
Dronedarone—Nausea—Docetaxel—head and neck cancer	0.000644	0.00439	CcSEcCtD
Dronedarone—ADRA2A—lymph node—head and neck cancer	0.000623	0.00311	CbGeAlD
Dronedarone—ABCB1—lymphoid tissue—head and neck cancer	0.000615	0.00307	CbGeAlD
Dronedarone—ABCB1—thyroid gland—head and neck cancer	0.000559	0.00279	CbGeAlD
Dronedarone—ABCB1—head—head and neck cancer	0.000496	0.00248	CbGeAlD
Dronedarone—ABCB1—lymph node—head and neck cancer	0.000347	0.00173	CbGeAlD
Dronedarone—ADRA2C—Metabolism—GPX1—head and neck cancer	4.28e-05	0.000353	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—CYP1A1—head and neck cancer	4.23e-05	0.00035	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—PTGS2—head and neck cancer	4.23e-05	0.00035	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—YAP1—head and neck cancer	4.23e-05	0.000349	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—PTEN—head and neck cancer	4.2e-05	0.000347	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—DPYD—head and neck cancer	4.2e-05	0.000347	CbGpPWpGaD
Dronedarone—CACNB3—Metabolism—AKT1—head and neck cancer	4.19e-05	0.000346	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—PIK3CA—head and neck cancer	4.09e-05	0.000338	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—YAP1—head and neck cancer	3.98e-05	0.000329	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—VEGFA—head and neck cancer	3.97e-05	0.000328	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—TP53—head and neck cancer	3.96e-05	0.000327	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—IL2—head and neck cancer	3.93e-05	0.000325	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL2—head and neck cancer	3.92e-05	0.000324	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—IL2—head and neck cancer	3.89e-05	0.000322	CbGpPWpGaD
Dronedarone—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	3.88e-05	0.000321	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.82e-05	0.000316	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—PIK3CA—head and neck cancer	3.82e-05	0.000316	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—HRAS—head and neck cancer	3.78e-05	0.000313	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—MAPK3—head and neck cancer	3.76e-05	0.000311	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—TP53—head and neck cancer	3.7e-05	0.000305	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—PTEN—head and neck cancer	3.69e-05	0.000305	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—IL2—head and neck cancer	3.69e-05	0.000305	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—TYMS—head and neck cancer	3.67e-05	0.000303	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—IL2—head and neck cancer	3.64e-05	0.000301	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—GSTM1—head and neck cancer	3.63e-05	0.0003	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.62e-05	0.000299	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—IL2—head and neck cancer	3.58e-05	0.000296	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—MAPK1—head and neck cancer	3.58e-05	0.000296	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL2—head and neck cancer	3.57e-05	0.000295	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL2—head and neck cancer	3.54e-05	0.000292	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—HRAS—head and neck cancer	3.53e-05	0.000292	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—GPX1—head and neck cancer	3.47e-05	0.000287	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CYP1A1—head and neck cancer	3.44e-05	0.000284	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NOTCH1—head and neck cancer	3.36e-05	0.000278	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—AKT1—head and neck cancer	3.34e-05	0.000276	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL2—head and neck cancer	3.3e-05	0.000273	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL2—head and neck cancer	3.25e-05	0.000269	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—IL2—head and neck cancer	3.18e-05	0.000263	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.16e-05	0.000261	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—MAPK3—head and neck cancer	3.15e-05	0.00026	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—VEGFA—head and neck cancer	3.14e-05	0.000259	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—PIK3CA—head and neck cancer	3.13e-05	0.000259	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NAT2—head and neck cancer	3.13e-05	0.000259	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—AKT1—head and neck cancer	3.12e-05	0.000258	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—PIK3CA—head and neck cancer	3.1e-05	0.000256	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NOTCH1—head and neck cancer	3.06e-05	0.000253	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NOTCH1—head and neck cancer	3.04e-05	0.000251	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—TP53—head and neck cancer	3e-05	0.000248	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—MAPK1—head and neck cancer	3e-05	0.000248	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—EGFR—head and neck cancer	3e-05	0.000248	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—MAPK3—head and neck cancer	2.97e-05	0.000245	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—PIK3CA—head and neck cancer	2.96e-05	0.000245	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—IL2—head and neck cancer	2.95e-05	0.000244	CbGpPWpGaD
Dronedarone—ALB—Metabolism—TYMS—head and neck cancer	2.9e-05	0.000239	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL2—head and neck cancer	2.89e-05	0.000239	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—HRAS—head and neck cancer	2.87e-05	0.000237	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—MAPK3—head and neck cancer	2.87e-05	0.000237	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—PIK3CA—head and neck cancer	2.86e-05	0.000237	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GSTM1—head and neck cancer	2.86e-05	0.000237	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—MAPK3—head and neck cancer	2.84e-05	0.000235	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NOTCH1—head and neck cancer	2.84e-05	0.000234	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—MAPK1—head and neck cancer	2.82e-05	0.000233	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NOTCH1—head and neck cancer	2.79e-05	0.000231	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—DPYD—head and neck cancer	2.74e-05	0.000227	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GPX1—head and neck cancer	2.74e-05	0.000227	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—MAPK1—head and neck cancer	2.73e-05	0.000226	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—EGFR—head and neck cancer	2.73e-05	0.000226	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYP1A1—head and neck cancer	2.71e-05	0.000224	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—MAPK1—head and neck cancer	2.71e-05	0.000224	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—EGFR—head and neck cancer	2.7e-05	0.000224	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL2—head and neck cancer	2.68e-05	0.000222	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—MAPK3—head and neck cancer	2.66e-05	0.000219	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—MAPK3—head and neck cancer	2.61e-05	0.000216	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—PIK3CA—head and neck cancer	2.61e-05	0.000216	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—PIK3CA—head and neck cancer	2.6e-05	0.000215	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—YAP1—head and neck cancer	2.6e-05	0.000215	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—PIK3CA—head and neck cancer	2.6e-05	0.000215	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—PIK3CA—head and neck cancer	2.58e-05	0.000214	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—AKT1—head and neck cancer	2.56e-05	0.000211	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—TYMS—head and neck cancer	2.54e-05	0.00021	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—AKT1—head and neck cancer	2.54e-05	0.00021	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—MAPK1—head and neck cancer	2.53e-05	0.000209	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—EGFR—head and neck cancer	2.53e-05	0.000209	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTGS2—head and neck cancer	2.52e-05	0.000208	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTM1—head and neck cancer	2.51e-05	0.000207	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—MAPK1—head and neck cancer	2.49e-05	0.000206	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—EGFR—head and neck cancer	2.49e-05	0.000205	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NOTCH1—head and neck cancer	2.48e-05	0.000205	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—PIK3CA—head and neck cancer	2.45e-05	0.000202	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—AKT1—head and neck cancer	2.42e-05	0.0002	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—PIK3CA—head and neck cancer	2.41e-05	0.0002	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—HRAS—head and neck cancer	2.41e-05	0.000199	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GPX1—head and neck cancer	2.4e-05	0.000199	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—TYMS—head and neck cancer	2.39e-05	0.000198	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYP1A1—head and neck cancer	2.38e-05	0.000197	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—PIK3CA—head and neck cancer	2.38e-05	0.000196	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—TP53—head and neck cancer	2.37e-05	0.000196	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—PIK3CA—head and neck cancer	2.37e-05	0.000196	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.36e-05	0.000195	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—PIK3CA—head and neck cancer	2.35e-05	0.000194	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—AKT1—head and neck cancer	2.34e-05	0.000193	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—MAPK3—head and neck cancer	2.32e-05	0.000192	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL2—head and neck cancer	2.31e-05	0.000191	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	2.3e-05	0.00019	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—HRAS—head and neck cancer	2.27e-05	0.000187	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GPX1—head and neck cancer	2.26e-05	0.000187	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCND1—head and neck cancer	2.26e-05	0.000186	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.24e-05	0.000185	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.23e-05	0.000184	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	2.21e-05	0.000183	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	2.21e-05	0.000183	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTEN—head and neck cancer	2.2e-05	0.000181	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—PIK3CA—head and neck cancer	2.19e-05	0.000181	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—HRAS—head and neck cancer	2.19e-05	0.000181	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PTEN—head and neck cancer	2.18e-05	0.00018	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—HRAS—head and neck cancer	2.17e-05	0.000179	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—PIK3CA—head and neck cancer	2.16e-05	0.000178	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	2.16e-05	0.000178	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—AKT1—head and neck cancer	2.13e-05	0.000176	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—AKT1—head and neck cancer	2.13e-05	0.000176	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—AKT1—head and neck cancer	2.12e-05	0.000176	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—AKT1—head and neck cancer	2.11e-05	0.000175	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	2.11e-05	0.000174	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL2—head and neck cancer	2.11e-05	0.000174	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL2—head and neck cancer	2.09e-05	0.000173	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCND1—head and neck cancer	2.06e-05	0.00017	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	2.05e-05	0.00017	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	2.05e-05	0.00017	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—head and neck cancer	2.05e-05	0.000169	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCND1—head and neck cancer	2.04e-05	0.000168	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—HRAS—head and neck cancer	2.03e-05	0.000168	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—AKT1—head and neck cancer	2e-05	0.000165	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	2e-05	0.000165	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTEN—head and neck cancer	1.98e-05	0.000164	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—AKT1—head and neck cancer	1.97e-05	0.000163	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—head and neck cancer	1.97e-05	0.000163	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTEN—head and neck cancer	1.97e-05	0.000162	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.96e-05	0.000162	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL2—head and neck cancer	1.95e-05	0.000161	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—STAT3—head and neck cancer	1.95e-05	0.000161	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	1.94e-05	0.00016	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—AKT1—head and neck cancer	1.94e-05	0.00016	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL2—head and neck cancer	1.92e-05	0.000159	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—AKT1—head and neck cancer	1.92e-05	0.000158	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	1.92e-05	0.000158	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCND1—head and neck cancer	1.9e-05	0.000157	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	1.87e-05	0.000155	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK3—head and neck cancer	1.86e-05	0.000154	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTEN—head and neck cancer	1.84e-05	0.000152	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	1.81e-05	0.000149	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—head and neck cancer	1.79e-05	0.000148	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—AKT1—head and neck cancer	1.79e-05	0.000148	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTEN—head and neck cancer	1.78e-05	0.000147	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.78e-05	0.000147	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—head and neck cancer	1.78e-05	0.000147	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—STAT3—head and neck cancer	1.77e-05	0.000147	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	1.77e-05	0.000147	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK1—head and neck cancer	1.77e-05	0.000146	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EGFR—head and neck cancer	1.77e-05	0.000146	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	1.76e-05	0.000146	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—STAT3—head and neck cancer	1.76e-05	0.000145	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	1.72e-05	0.000142	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL2—head and neck cancer	1.71e-05	0.000141	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK3—head and neck cancer	1.69e-05	0.00014	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK3—head and neck cancer	1.68e-05	0.000139	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	1.66e-05	0.000137	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—head and neck cancer	1.66e-05	0.000137	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	1.65e-05	0.000136	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—STAT3—head and neck cancer	1.64e-05	0.000136	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	1.63e-05	0.000135	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	1.62e-05	0.000134	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—head and neck cancer	1.61e-05	0.000133	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK1—head and neck cancer	1.61e-05	0.000133	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EGFR—head and neck cancer	1.61e-05	0.000133	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	1.61e-05	0.000133	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	1.6e-05	0.000132	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK1—head and neck cancer	1.6e-05	0.000132	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EGFR—head and neck cancer	1.6e-05	0.000132	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL2—head and neck cancer	1.58e-05	0.000131	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK3—head and neck cancer	1.57e-05	0.00013	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	1.57e-05	0.000129	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—TYMS—head and neck cancer	1.56e-05	0.000129	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PIK3CA—head and neck cancer	1.55e-05	0.000128	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.55e-05	0.000128	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	1.55e-05	0.000128	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	1.54e-05	0.000128	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PIK3CA—head and neck cancer	1.54e-05	0.000127	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK1—head and neck cancer	1.49e-05	0.000123	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EGFR—head and neck cancer	1.49e-05	0.000123	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	1.49e-05	0.000123	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—head and neck cancer	1.49e-05	0.000123	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GPX1—head and neck cancer	1.48e-05	0.000122	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	1.47e-05	0.000121	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	1.47e-05	0.000121	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.47e-05	0.000121	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	1.45e-05	0.00012	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	1.45e-05	0.00012	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	1.44e-05	0.000119	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HRAS—head and neck cancer	1.42e-05	0.000117	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—head and neck cancer	1.41e-05	0.000117	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTEN—head and neck cancer	1.41e-05	0.000116	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PIK3CA—head and neck cancer	1.4e-05	0.000116	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PIK3CA—head and neck cancer	1.39e-05	0.000115	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	1.37e-05	0.000113	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—head and neck cancer	1.35e-05	0.000112	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	1.35e-05	0.000111	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—head and neck cancer	1.34e-05	0.000111	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	1.33e-05	0.00011	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.33e-05	0.00011	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	1.3e-05	0.000108	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	1.3e-05	0.000108	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CA—head and neck cancer	1.3e-05	0.000107	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HRAS—head and neck cancer	1.29e-05	0.000107	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HRAS—head and neck cancer	1.28e-05	0.000106	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	1.27e-05	0.000105	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	1.27e-05	0.000105	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—AKT1—head and neck cancer	1.27e-05	0.000105	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CA—head and neck cancer	1.26e-05	0.000104	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—AKT1—head and neck cancer	1.25e-05	0.000104	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—head and neck cancer	1.25e-05	0.000104	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTEN—head and neck cancer	1.23e-05	0.000102	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—head and neck cancer	1.23e-05	0.000102	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	1.21e-05	0.0001	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	1.21e-05	0.0001	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HRAS—head and neck cancer	1.2e-05	9.9e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	1.18e-05	9.75e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTEN—head and neck cancer	1.16e-05	9.6e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—AKT1—head and neck cancer	1.14e-05	9.45e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—AKT1—head and neck cancer	1.13e-05	9.36e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	1.13e-05	9.36e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—head and neck cancer	1.1e-05	9.05e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—AKT1—head and neck cancer	1.06e-05	8.74e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	1.05e-05	8.69e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	1.05e-05	8.66e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	1.04e-05	8.61e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—AKT1—head and neck cancer	1.03e-05	8.49e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—head and neck cancer	1.02e-05	8.41e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CA—head and neck cancer	9.93e-06	8.21e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	9.73e-06	8.04e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	9.25e-06	7.64e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—head and neck cancer	8.71e-06	7.2e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CA—head and neck cancer	8.7e-06	7.19e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	8.59e-06	7.1e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CA—head and neck cancer	8.2e-06	6.78e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AKT1—head and neck cancer	8.11e-06	6.7e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTEN—head and neck cancer	7.6e-06	6.28e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AKT1—head and neck cancer	7.11e-06	5.87e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AKT1—head and neck cancer	6.7e-06	5.53e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.36e-06	4.43e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AKT1—head and neck cancer	4.38e-06	3.62e-05	CbGpPWpGaD
